AI-driven prognostics in pediatric bone marrow transplantation: a CAD approach with Bayesian and PSO optimization. [PDF]
Badawy M +7 more
europepmc +1 more source
Treatment of Chronic Myeloid Leukemia Relapsing After Allogeneic Bone Marrow Transplantation: The Case for Giving Interferon [PDF]
Juan Luis Steegmann +3 more
openalex +1 more source
The KDM6B/SLC10A2 Axis Suppresses MDSCs Recruitment via ERK/AP‐1 Signaling in Colorectal Cancer
In wild‐type intestinal epithelial cells, KDM6B demethylates SLC10A2 to promote its expression, after which SLC10A2 suppresses ERK phosphorylation, inhibiting AP‐1 (Fos/Jun) transcription and chemokine production. In KDM6B‐deficient intestinal epithelial cells, SLC10A2 methylation increases, and its expression decreases.
Zhibo Hu +16 more
wiley +1 more source
A Pilot Study of Bone Marrow Transplantation in a GALT-Null Rat Model of Classic Galactosemia. [PDF]
Rasmussen SA +6 more
europepmc +1 more source
Targeting the Spleen as an Alternative Site for Hematopoiesis [PDF]
Lim, Hong +3 more
core +1 more source
Challenging the focus on age, this study finds pre‐existing T helper 1 cells are the key biomarker for predicting antibody response to SARS‐CoV‐2 inactivated vaccines. In both mice and humans, high responders exhibited elevated baseline T helper 1 cells, which correlated with robust humoral immunity, offering crucial guidance for improving vaccine ...
Chanyuan Ye +12 more
wiley +1 more source
Bone marrow transplantation for leukocyte adhesion deficiency type III: immunosuppressant dosage adjustments against severe T-cell mixed chimerism. [PDF]
Koike T +6 more
europepmc +1 more source
Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse [PDF]
JE van Leeuwen +6 more
openalex +1 more source
Corticosteroids improve the efficacy of immune checkpoint blockade therapy in metastatic murine breast cancer. By normalizing the tumor immune microenvironment, corticosteroids reduce immunosuppressive signals, restore T‐cell function, and promote antitumor immune responses, resulting in enhanced tumor control.
John D. Martin +19 more
wiley +1 more source

